ArticleDiagnostics (Basel, Switzerland)2025

Claudin-4 Overexpression Predicts Poor Survival and Platinum Resistance in Epithelial Ovarian Cancer: A Potential Biomarker for Clinical Decision-Making.

Özlem Kutlu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.